Who is sponsoring PNE?

PNE is sponsored by Ferring Pharmaceuticals.

What condition does PNE study?

PNE studies Nocturnal Enuresis.

What drugs are being tested in PNE?

Interventions: Desmopressin, Placebo.

Last reviewed 2011-09-27 · How we verify

A Double-blind, Placebo-controlled, Phase III Comparative Study With FE992026 in Children and Adolescents With Reduced Night-time Urinary Osmolarity-type Nocturnal Enuresis (PNE)

NCT01078753 Phase 3 COMPLETED Results posted

This is multi-center, randomized, placebo-controlled, parallel-group, double-blind, dose-escalating clinical trial designed to assess the efficacy and safety of desmopressin orally lyophilisate for the treatment of nocturnal enuresis "with decreased nighttime urinary osmolality."

Details

Lead sponsor	Ferring Pharmaceuticals
Phase	Phase 3
Status	COMPLETED
Enrolment	89
Start date	2010-01
Completion	2010-09

Conditions

Nocturnal Enuresis

Interventions

Desmopressin
Placebo

Primary outcomes

Change in the Number of Wet Nights Between Baseline and Treatment Period II — Baseline (14-day period prior to starting study treatment) and Treatment Period II (weeks 3-4 after treatment initiation).
The number of wet nights was recorded by participants (or their caregivers) in a daily diary. The difference was calculated from the number of wet nights during the 14-day Baseline Period minus the number of wet nights during the 14-day Treatment Period II.

Countries

Japan